Deprescribing in the time of covid-19

This editorial discusses current uncertainty around which medicines could be problematic for people with or at risk of Covid-19, and argues that unless there is clear evidence to support an urgent change to patients’ medicines, deprescribing should wait until the pandemic is over


Drug and Therapeutics Bulletin